TORONTO, Oct. 24 /PRNewswire-FirstCall/ - Further to its press release of October 20, 2006, predictive medicine company PreMD Inc. (TSX: PMD - News; Amex: PME - News; “PreMD”) today announced that it has commenced an action in the Ontario Superior Court of Justice in Toronto against Dr. Abulkalam K.M. Shamsuddin (“Shamsuddin”), Stuart Brazier (“Brazier”) and Med-11 AG (“Med-11") in connection with its 1998 license agreement with Shamsuddin (the “License Agreement”), pursuant to which Shamsuddin granted an exclusive license to PreMD relating to certain intellectual property involving part of PreMD’s cancer products, which include ColorectAlert(TM), LungAlert(TM) and a breast cancer test.
